PerkinElmer Life Sciences of Boston last week announced the full commercial debut of its Protein Array Workstation, an automated slide-based protein microarray processor. The system was developed in collaboration with NexGen Sciences of the UK, and beta- models were unveiled last spring. The ProteinArray Workstation employs a microfluidics system, full software control interface and bar code tracking capability for future integration into PerkinElmer's other protein microarray technologies, the company said. The system can expand to process up to 48 protein microarrays and can use very low sample volumes. The workstation allows automated sample introduction for unattended operation, and can inject up to two separate samples per protein microarray. The system has been developed with an on-line reagent blending facility, the company said.
NTT Software of Boston announced last week the launch of its VisualBio bioinformatics product. The product, which helps researchers visualize gene sequence information, was developed in a partnership with NTT and Riken Genomic Sciences Center in Japan. The products are priced from $16,129.
Qiagen rolled out array-ready oligonucleotide sets for Arabidopsis, Candida albicans, Caenorhabditis elegans, and Drosophila melanogaster genomes. The sets contain 70-mer probes and 26,090, 6266, 7125, and 14,593 characterized genes and/or open reading frames (ORFs), respectively, the company said.
Separately, Qiagen has entered into a non-exclusive licensing agreement to sell Epoch Bioscience's MGB Eclipse Probe gene expression chemistry, the companies said. Epoch will supply components exclusively to Qiagen, which will begin selling custom and standard probe systems in early 2003.